| abstract |
The present application relates to a pharmaceutical composition containing substances contained in Cimicifuga Racemosa extract, or derivatives thereof with steroidal estrogen effect. This composition, however, does not have the steroidal estrogen side-effect of increasing the risk of development or the tendency to relapse of breast cancer and are thus suitable for relieving or curing symptoms or diseases which are caused by estrogen deficiency or which can be relieved or cured by administration of steriodal estrogen, in women, who suffer from breast cancer, or have a risk of recurrent breast cancer, or have a high risk of developing breast cancer. The application further relates to the uses of such compositions and methods for identifying same. |